InvestorsHub Logo
Followers 14
Posts 2307
Boards Moderated 0
Alias Born 01/02/2003

Re: boi568 post# 298543

Friday, 02/12/2021 10:10:07 AM

Friday, February 12, 2021 10:10:07 AM

Post# of 462172
boid568, possible that Dr.M might have taken it into consideration. However, since the company made it clear (in multiple communications/clarifications to investors), I would still take it as two separate tracks and two different approaches (considering the amount of studies done on ALZ patients and the positive results within Australia as opposed to RETT). Of course, since getting permission under SAS is still a process for the patients and doctors, you would see a slower take (as opposed to something available by simple prescription) and hence handling the commercial and supply aspect shouldn't be an issue...yet (a good problem to have though).

-vg_future
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News